The University of Missouri’s Coulter Biomedical Accelerator Program received three grants worth over $200,000 to help promising medical discoveries make the transition from laboratory research to commercial investment and use in direct patient care.
“The University of Missouri is home to leading experts in all fields of engineering, medicine and business,” said Mark McIntosh, PhD, MU vice chancellor for research and economic development. “The Coulter Biomedical Accelerator Program brings this expertise together with the goal of delivering practical solutions to pressing medical problems affecting our state, nation and the world. The Coulter Program is an excellent example of the power of interdisciplinary collaborations at MU.”
